跳至主要内容
临床试验/TCTR20230214003
TCTR20230214003招募中4 期

The study to evaluate the efficacy and safety of Polynucleotide for Periorbital Rejuvenation in Thailand

SW HEALTHCARE CO.,LTD0 个研究点目标入组 25 人开始时间: 2023年2月14日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 55 Years(—)
性别
All

入选标准

  • 1. Aged 25-55 years old
  • 2. Both male and female
  • 3. Grade 1-5 wrinkle at periorbital by Wrinkle Assessment Scale of periorbital lines

排除标准

  • 1. Subjects who are pregnant
  • 2. Subjects who had history of low platelet, coagulopathy or taking medicine of antocoagulant drug like warfarin
  • 3. Subjects who has dermatits, wound or infection at treatment area
  • 4. Subjects who allergy to anesthesia cream
  • 5. Subjects who taken oral or injection contraceptive pills
  • 6. Subjects who had history of laser, filler and botox at treatment area within 6 months before arrived the project
  • 7. Subjects who had history of keloid or hypertrophic scar
  • 8. Subjects who had history of psychitic disease

研究者

发起方
SW HEALTHCARE CO.,LTD

相似试验

The study to evaluate the efficacy and safety of... | 临床试验